Click Therapeutics Unveils New Brand Identity to Strengthen Leadership in Software as Prescription Treatments

Click Therapeutics Unveils New Brand Identity to Strengthen Leadership in Software as Prescription Treatments Click Therapeutics, Inc. (“Click”), a pioneer in the development of prescription medical treatments, has unveiled a new brand identity and website to reflect its evolution and…

Read MoreClick Therapeutics Unveils New Brand Identity to Strengthen Leadership in Software as Prescription Treatments

Geneoscopy Appoints Amit Bhalla as CFO to Drive Growth and Commercialization

Geneoscopy Appoints Amit Bhalla as CFO to Drive Growth and Commercialization Geneoscopy, Inc., a life sciences company focused on advancing gastrointestinal health through innovative diagnostic tests, has announced the appointment of Amit Bhalla as its Chief Financial Officer (CFO). With…

Read MoreGeneoscopy Appoints Amit Bhalla as CFO to Drive Growth and Commercialization
Allurion Technologies

NanoVibronix Announces Distribution Agreement with Dukehill Healthcare in Australia

NanoVibronix Announces Distribution Agreement with Dukehill Healthcare in Australia NanoVibronix, Inc. (NASDAQ: NAOV), a leading medical technology company specializing in non-invasive therapeutic devices, has announced the renewal and expansion of its exclusive three-year distribution agreement with Dukehill Healthcare Pty Ltd.…

Read MoreNanoVibronix Announces Distribution Agreement with Dukehill Healthcare in Australia

ZAP-X Gyroscopic Radiosurgery Platform Debuts at Kaohsiung Show Chwan Memorial Hospital

ZAP-X Gyroscopic Radiosurgery Platform Debuts at Kaohsiung Show Chwan Memorial Hospital ZAP Surgical Systems, Inc., a leader in non-invasive robotic brain surgery, has announced the installation of Taiwan’s first vault-free ZAP-X® Gyroscopic Radiosurgery® platform at Kaohsiung Show Chwan Memorial Hospital…

Read MoreZAP-X Gyroscopic Radiosurgery Platform Debuts at Kaohsiung Show Chwan Memorial Hospital

RenovoRx Reports Initial Revenues from RenovoCath® and Phase III TIGeR-PaC Trial Update

RenovoRx Reports Initial Revenues from RenovoCath® and Phase III TIGeR-PaC Trial Update RenovoRx, Inc. (Nasdaq: RNXT), a life sciences company focused on developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel FDA-cleared drug delivery device, has announced its financial…

Read MoreRenovoRx Reports Initial Revenues from RenovoCath® and Phase III TIGeR-PaC Trial Update

Siemens Healthineers’ Antithrombin Blood Test FDA Cleared as Companion Diagnostic for Sanofi’s Qfitlia Hemophilia Therapy

Siemens Healthineers’ Antithrombin Blood Test FDA Cleared as Companion Diagnostic for Sanofi’s Qfitlia Hemophilia Therapy Siemens Healthineers announced that its Innovance Antithrombin assay has received FDA clearance for a new indication, allowing it to be used as a companion diagnostic…

Read MoreSiemens Healthineers’ Antithrombin Blood Test FDA Cleared as Companion Diagnostic for Sanofi’s Qfitlia Hemophilia Therapy